Clinic
Kidmed Southside PLC
Kidmed Southside PLC was paid $2.36M by Medicaid between Jan 2018 and Oct 2022, across 26 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 38% of everything it billed.
33Billing provider infoKIDMED SOUTHSIDE PLC
MIDLOTHIAN, VA 23112
MIDLOTHIAN, VA 23112
33aNPI1477869337assigned 08/28/2010
33bProvider typeUrgent Care Clinic/Center
28Total paid$2.36M
24GClaims44,826
24DCodes billed26
24AFirst – last monthJan 2018 – Oct 2022
Compared with peers
Next to other Urgent Care Clinic/Center providers in Virginia
Rank by total paid#10 of 51
Median peer was paid$182K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,788 | $452K | |
| 2019 | 12,124 | $647K | |
| 2020 | 7,359 | $466K | |
| 2021 | 9,300 | $471K | |
| 2022 | 6,255 | $321K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 11,842 | 10,947 | $888K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 16% | 3,565 | 3,401 | $383K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 5,119 | 4,766 | $262K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 11% | 3,490 | 3,371 | $249K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6.2% | 4,492 | 4,325 | $145K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.8% | 1,559 | 1,498 | $112K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.7% | 2,007 | 1,878 | $86K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.4% | 3,157 | 2,877 | $80K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 3,233 | 3,004 | $40K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 740 | 711 | $30K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 2,436 | 1,072 | $30K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 537 | 506 | $18K |
14 more codes
| 87634 | <1% | 216 | $9K | |
| 99051 | <1% | 760 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 294 | $6K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 53 | $3K |
| 87807 | <1% | 195 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 161 | $2K |
| 81003 | <1% | 511 | $915.48 | |
| 87428 | <1% | 15 | $566.21 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 34 | $484.13 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 158 | $179.12 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 138 | $26.00 |
| 99000 | <1% | 26 | $3.86 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 71 | $2.02 |
| X0002 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFLANZENBAUM, MARK (PRESIDENT/MANAGING PARTNER)
Parent organizationKIDMED INC
| Provider | Location | Paid |
|---|---|---|
| Kidmed INC. | Glen Allen, VA | $17.40M |
| Kidmed INC. | Mechanicsville, VA | $23K |
| Kidmed INC. | Stafford, VA | $82.87 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.